Provencher, Lorraine M.
Fairbanks, Aaron M.
Abramoff, Michael D.
Syed, Nasreen A. http://orcid.org/0000-0002-7192-0774
Article History
Received: 30 April 2018
Accepted: 12 December 2018
First Online: 29 December 2018
Ethics approval and consent to participate
: This study was approved by the University of Iowa Institutional Review Board, adhered to the tenets of the Declaration of Helsinki, and was compliant with the Health Insurance Portability and Accountability Act. Waiver of documentation of consent and waiver of elements of consent were granted due to the retrospective nature of the study.
: Identifiable individual patient data was not included in the study and therefore consent to publish from individual patients was not obtained or required.
: The authors declare that they have no competing interests related to this work. MDA has the following financial interests and consultancy: IDx LLC, Iowa City, IA, founder; IDx LLC, Iowa City, IA, investor (equity interests); IDx LLC, Iowa City, IA, consultant; IDx LLC, Iowa City, IA, president; Gerson Lehrman Group, consultant, expert testimony; iOptics BV, Amsterdam Netherlands, founder; iOptics BV, Amsterdam Netherlands, investor (equity interests); EASDEC invited speaker; EU retina invited speaker; ATA invited speaker; and MICCAI invited speaker. Dr. Abràmoff has the following intellectual property leading to royalties: University of Iowa patents, University of Iowa patent applications, IDx LLC patents, IDx LLC patent applications.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.